Panorama

Skyline and Panorama: Key Tools for Establishing a Targeted LC/MS Workflow

Kristin Wildsmith

OMNI Biomarker Development, Development Sciences, Genentech, Inc. (a member of the Roche Group)

 

How LabKey is Accelerating Biomarker Development

Although identification and development of clinically relevant biomarkers is challenging, they are critical for successful drug development and for ensuring the right drugs are given the right patients. Targeted mass spectrometry is one key technology we employ to evaluate candidate biomarkers. Due to its ability to support a multitude of different LC/MS assay and instrument types, we are partnering with LabKey and the University of Washington through the Panorama Partnership program to implement and refine a Skyline centric LC/MS data workflow.

Skyline is an open-source software for targeted LC/MS method development, and Panorama (implemented through LabKey Server), is a data management platform supporting Skyline. They enable us to create, organize, share, search and analyze our data. This includes the ability to track instrument performance and build libraries required to support discovery proteomics approaches. Our vision is to utilize Skyline and Panorama in partnership with LabKey to streamline our LC/MS workflow in order to impact clinical programs through accelerated biomarker discovery and development.

See how others have succeeded with LabKey

Harmonizing Data Management at BIOASTER with Server SDMS

Learn more
learnmore

Transforming Sample Management at Biodesix

Learn more
learnmore

Upgrading Sample Tracking for Biomarker Research at Candel Therapeutics

Learn more
learnmore

Sample Manager at CU Anschutz

Learn more
learnmore

Sample Manager at BrainChild Bio

Learn more
learnmore

Sample Manager at Gameto

Learn more
learnmore

Book a demo to learn more about LabKey.